Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast CancerStephen Chan, John Crown, I. Bodrogi et al.|Journal of Clinical Oncology|1999Cited by 639
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation studyPhilippe Moreau, Jean‐Paul Fermand, Arnaud Jaccard et al.|Blood|2010Cited by 132
A Multicenter Phase I/II Dose Escalation Study of Lenalidomide in Combination with Melphalan and Dexamethasone in Subjects with Newly-Diagnosed Light-Chain (AL)-Amyloidosis.Philippe Moreau, Jean‐Paul Fermand, Arnaud Jaccard et al.|Blood|2008Cited by 3
Pharmacokinetics, Efficacy and Safety of Lenalidomide (Len) in Myeloma Patients with Renal Impairment: Results From the Prospective Study “REVIR”Frank Bridoux, Jean Paul Fermand, Bertrand Arnulf et al.|Blood|2011Cited by 2